{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T17:17:16Z","timestamp":1790443036943,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.biopsych.2008.12.022","type":"journal-article","created":{"date-parts":[[2009,2,22]],"date-time":"2009-02-22T02:19:04Z","timestamp":1235269144000},"page":"146-153","source":"Crossref","is-referenced-by-count":36,"title":["Cabergoline Decreases Alcohol Drinking and Seeking Behaviors Via Glial Cell Line-Derived Neurotrophic Factor"],"prefix":"10.1016","volume":"66","author":[{"given":"Sebastien","family":"Carnicella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somayeh","family":"Ahmadiantehrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dao-Yao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten K.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selena E.","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia H.","family":"Janak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorit","family":"Ron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2008.12.022_bib1","series-title":"WHO global status report on alcohol 2004","year":"2004"},{"key":"10.1016\/j.biopsych.2008.12.022_bib2","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.pharmthera.2006.02.001","article-title":"Pharmacological treatment of alcohol dependence: Target symptoms and target mechanisms","volume":"111","author":"Heilig","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.biopsych.2008.12.022_bib3","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/YCO.0b013e3280fa837d","article-title":"The treatment of alcohol dependence","volume":"20","author":"Assanangkornchai","year":"2007","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.biopsych.2008.12.022_bib4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bcp.2007.08.005","article-title":"Update on neuropharmacological treatments for alcoholism: Scientific basis and clinical findings","volume":"75","author":"Johnson","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.biopsych.2008.12.022_bib5","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1360-0443.2004.00763.x","article-title":"Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: A systematic review","volume":"99","author":"Bouza","year":"2004","journal-title":"Addiction"},{"key":"10.1016\/j.biopsych.2008.12.022_bib6","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1124\/jpet.102.039867","article-title":"Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor","volume":"303","author":"Millan","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2008.12.022_bib7","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1124\/jpet.102.039875","article-title":"Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor","volume":"303","author":"Newman-Tancredi","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2008.12.022_bib8","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1124\/jpet.102.039883","article-title":"Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor","volume":"303","author":"Newman-Tancredi","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2008.12.022_bib9","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000077451","article-title":"Cabergoline stimulates synthesis and secretion of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor by mouse astrocytes in primary culture","volume":"71","author":"Ohta","year":"2004","journal-title":"Pharmacology"},{"key":"10.1016\/j.biopsych.2008.12.022_bib10","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0024-3205(03)00321-7","article-title":"Effects of dopamine agonists bromocriptine, pergolide, cabergoline, and SKF-38393 on GDNF, NGF, and BDNF synthesis in cultured mouse astrocytes","volume":"73","author":"Ohta","year":"2003","journal-title":"Life Sci"},{"key":"10.1016\/j.biopsych.2008.12.022_bib11","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrn812","article-title":"The GDNF family: Signalling, biological functions and therapeutic value","volume":"3","author":"Airaksinen","year":"2002","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.biopsych.2008.12.022_bib12","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1126\/science.8493557","article-title":"GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons","volume":"260","author":"Lin","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2008.12.022_bib13","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nn.2136","article-title":"Absolute requirement of GDNF for adult catecholaminergic neuron survival","volume":"11","author":"Pascual","year":"2008","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.biopsych.2008.12.022_bib14","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/373339a0","article-title":"Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain","volume":"373","author":"Beck","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2008.12.022_bib15","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/cne.1400","article-title":"GFRalpha-1 mRNA in dopaminergic and nondopaminergic neurons in the substantia nigra and ventral tegmental area","volume":"441","author":"Sarabi","year":"2001","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.biopsych.2008.12.022_bib16","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1523\/JNEUROSCI.17-10-03554.1997","article-title":"Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-alpha indicates multiple mechanisms of trophic actions in the adult rat CNS","volume":"17","author":"Trupp","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2008.12.022_bib17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0896-6273(00)80557-7","article-title":"Neuroscience of addiction","volume":"21","author":"Koob","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2008.12.022_bib18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0166-4328(99)00022-4","article-title":"Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies","volume":"101","author":"McBride","year":"1999","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.biopsych.2008.12.022_bib19","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1523\/JNEUROSCI.3959-04.2005","article-title":"Glial cell line-derived neurotrophic factor mediates the desirable actions of the anti-addiction drug ibogaine against alcohol consumption","volume":"25","author":"He","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2008.12.022_bib20","doi-asserted-by":"crossref","first-page":"8114","DOI":"10.1073\/pnas.0711755105","article-title":"GDNF is a fast-acting potent inhibitor of alcohol consumption and relapse","volume":"105","author":"Carnicella","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2008.12.022_bib21","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1248\/bpb.19.1499","article-title":"Effect of cabergoline, a long-acting dopamine D2 agonist, on reserpine-treated rodents","volume":"19","author":"Miyagi","year":"1996","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.biopsych.2008.12.022_bib22","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1248\/bpb.19.1210","article-title":"Dopamine receptor affinities in vitro and stereotypic activities in vivo of cabergoline in rats","volume":"19","author":"Miyagi","year":"1996","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.biopsych.2008.12.022_bib23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.alcohol.2008.12.001","article-title":"Excessive alcohol consumption is blocked by GDNF","volume":"43","author":"Carnicella","year":"2009","journal-title":"Alcohol"},{"key":"10.1016\/j.biopsych.2008.12.022_bib24","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF00414034","article-title":"Voluntary ethanol intake in rats following exposure to ethanol on various schedules","volume":"29","author":"Wise","year":"1973","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.biopsych.2008.12.022_bib25","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.biopsych.2008.12.022_bib26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.brainresrev.2007.05.004","article-title":"Dopamine reward circuitry: Two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex","volume":"56","author":"Ikemoto","year":"2007","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.biopsych.2008.12.022_bib27","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1523\/JNEUROSCI.1319-03.2004","article-title":"Intracranial self-administration of ethanol within the ventral tegmental area of male Wistar rats: Evidence for involvement of dopamine neurons","volume":"24","author":"Rodd","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2008.12.022_bib28","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0006-3223(02)01546-9","article-title":"Context, ambiguity, and unlearning: Sources of relapse after behavioral extinction","volume":"52","author":"Bouton","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2008.12.022_bib29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0163-7258(02)00200-0","article-title":"Neurobiology of relapse to alcohol in rats","volume":"94","author":"Le","year":"2002","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.biopsych.2008.12.022_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-006-0529-6","article-title":"Toward a model of drug relapse: An assessment of the validity of the reinstatement procedure","volume":"189","author":"Epstein","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2008.12.022_bib31","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/bjp.2008.30","article-title":"Neuropharmacology of alcohol addiction","volume":"154","author":"Vengeliene","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.biopsych.2008.12.022_bib32","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1046\/j.1460-9568.2002.02256.x","article-title":"Apomorphine induces trophic factors that support fetal rat mesencephalic dopaminergic neurons in cultures","volume":"16","author":"Guo","year":"2002","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biopsych.2008.12.022_bib33","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1111\/j.1460-9568.2005.04438.x","article-title":"Dopamine D3 receptor-preferring agonists induce neurotrophic effects on mesencephalic dopamine neurons","volume":"22","author":"Du","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biopsych.2008.12.022_bib34","doi-asserted-by":"crossref","first-page":"12518","DOI":"10.1073\/pnas.0705368104","article-title":"Varenicline, an {alpha}4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking","volume":"104","author":"Steensland","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2008.12.022_bib35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1369-1600.2006.00004.x","article-title":"Schedule-induced alcohol drinking: Non-selective effects of acamprosate and naltrexone","volume":"11","author":"Escher","year":"2006","journal-title":"Addict Biol"},{"key":"10.1016\/j.biopsych.2008.12.022_bib36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0376-8716(81)90084-3","article-title":"Aversive effects of naltrexone in subjects not dependent on opiates","volume":"8","author":"Hollister","year":"1981","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.biopsych.2008.12.022_bib37","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1176\/ajp.142.9.1081","article-title":"Naltrexone-induced dysphoria in former opioid addicts","volume":"142","author":"Crowley","year":"1985","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2008.12.022_bib38","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1523\/JNEUROSCI.4749-06.2007","article-title":"Ethanol induces long-term facilitation of NR2B-NMDA receptor activity in the dorsal striatum: Implications for alcohol drinking behavior","volume":"27","author":"Wang","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2008.12.022_bib39","doi-asserted-by":"crossref","first-page":"8665","DOI":"10.1523\/JNEUROSCI.0925-05.2005","article-title":"Involvement of the dorsal striatum in cue-controlled cocaine seeking","volume":"25","author":"Vanderschuren","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2008.12.022_bib40","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1523\/JNEUROSCI.3786-05.2006","article-title":"The dopamine D3 receptor is part of a homeostatic pathway regulating ethanol consumption","volume":"26","author":"Jeanblanc","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2008.12.022_bib41","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/nn1579","article-title":"Neural systems of reinforcement for drug addiction: From actions to habits to compulsion","volume":"8","author":"Everitt","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.biopsych.2008.12.022_bib42","doi-asserted-by":"crossref","first-page":"6583","DOI":"10.1523\/JNEUROSCI.1544-06.2006","article-title":"Cocaine cues and dopamine in dorsal striatum: Mechanism of craving in cocaine addiction","volume":"26","author":"Volkow","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2008.12.022_bib43","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/sj.npp.1301263","article-title":"There and back again: A tale of norepinephrine and drug addiction","volume":"32","author":"Weinshenker","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2008.12.022_bib44","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1111\/j.1460-9568.2004.03700.x","article-title":"Increased extracellular dopamine concentrations and FosB\/DeltaFosB expression in striatal brain areas of heterozygous GDNF knockout mice","volume":"20","author":"Airavaara","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biopsych.2008.12.022_bib45","article-title":"GDNF\u2014A potential target to treat addiction [published online ahead of print December 24]","author":"Carnicella","year":"2008","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.biopsych.2008.12.022_bib46","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1146\/annurev.neuro.29.051605.113009","article-title":"Neural mechanisms of addiction: The role of reward-related learning and memory","volume":"29","author":"Hyman","year":"2006","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.biopsych.2008.12.022_bib47","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/syn.890210403","article-title":"Biochemical actions of chronic ethanol exposure in the mesolimbic dopamine system","volume":"21","author":"Ortiz","year":"1995","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2008.12.022_bib48","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0896-6273(00)81154-X","article-title":"Role for GDNF in biochemical and behavioral adaptations to drugs of abuse","volume":"26","author":"Messer","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2008.12.022_bib49","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.biopsych.2006.06.016","article-title":"An inducer for glial cell line-derived neurotrophic factor and tumor necrosis factor-alpha protects against methamphetamine-induced rewarding effects and sensitization","volume":"61","author":"Niwa","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2008.12.022_bib50","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/ncpendmet0160","article-title":"Drug insight: Cabergoline and bromocriptine in the treatment of hyperprolactinemia in men and women","volume":"2","author":"Colao","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.biopsych.2008.12.022_bib51","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJM199410063311403","article-title":"A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea","volume":"331","author":"Webster","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biopsych.2008.12.022_bib52","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2165\/00023210-200721080-00005","article-title":"Medical management of levodopa-associated motor complications in patients with Parkinson's disease","volume":"21","author":"Jankovic","year":"2007","journal-title":"CNS Drugs"},{"issue":"Suppl 1","key":"10.1016\/j.biopsych.2008.12.022_bib53","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/00019052-200312001-00004","article-title":"Comparing dopamine agonists in Parkinson's disease","volume":"16","author":"Bonuccelli","year":"2003","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.biopsych.2008.12.022_bib54","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1530\/EJE-08-0611","article-title":"Cabergoline and cardiac valve disease in prolactinoma patients: Additional studies during long-term treatment are required","volume":"159","author":"Kars","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.biopsych.2008.12.022_bib55","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2265.2006.02461.x","article-title":"The treatment with cabergoline for 24 month normalizes the quality of seminal fluid in hyperprolactinaemic males","volume":"64","author":"De Rosa","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.biopsych.2008.12.022_bib56","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1210\/jc.2007-1403","article-title":"Increased prevalence of tricuspid regurgitation in patients with prolactinomas chronically treated with cabergoline","volume":"93","author":"Colao","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.biopsych.2008.12.022_bib57","doi-asserted-by":"crossref","DOI":"10.1111\/j.1742-1241.2008.01779.x","article-title":"Treatment with low doses of cabergoline is not associated with increased prevalence of cardiac valve regurgitation in patients with hyperprolactinaemia","author":"Bogazzi","year":"2008","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.biopsych.2008.12.022_bib58","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0014-2999(90)90367-F","article-title":"In vivo interaction of cabergoline with rat brain dopamine receptors labelled with [3H]N-n-propylnorapomorphine","volume":"187","author":"Benedetti","year":"1990","journal-title":"Eur J Pharmacol"},{"issue":"suppl 1","key":"10.1016\/j.biopsych.2008.12.022_bib59","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1360-0443.2005.00991.x","article-title":"Randomized controlled pilot trial of cabergoline, hydergine and levodopa\/carbidopa: Los Angeles Cocaine Rapid Efficacy Screening Trial (CREST)","volume":"100","author":"Shoptaw","year":"2005","journal-title":"Addiction"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322308016028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322308016028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T01:30:17Z","timestamp":1558143017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322308016028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0006322308016028"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2008.12.022","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}